Detalhe da pesquisa
1.
Treatment of muscle-invasive and advanced bladder cancer in 2020.
CA Cancer J Clin
; 70(5): 404-423, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32767764
2.
Biomarker Development Trial of Satraplatin in Patients with Metastatic Castration-Resistant Prostate Cancer.
Oncologist
; 28(4): 366-e224, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36519763
3.
Global DNA methylation of WTC prostate cancer tissues show signature differences compared to non-exposed cases.
Carcinogenesis
; 43(6): 528-537, 2022 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35239955
4.
Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma.
Oncologist
; 27(6): 476-486, 2022 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35298662
5.
Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma.
Oncologist
; 27(6): 432-e452, 2022 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35438782
6.
Impact of body mass index on the efficacy of aromatase inhibitors in patients with metastatic breast cancer.
Breast Cancer Res Treat
; 192(2): 313-319, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35006484
7.
Consensus report: Definition and interpretation of remission in type 2 diabetes.
Diabet Med
; 39(3): e14669, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34460965
8.
Factors that guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer.
Clin Adv Hematol Oncol
; 20 Suppl 9(5): 1-20, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579577
9.
Consensus report: definition and interpretation of remission in type 2 diabetes.
Diabetologia
; 64(11): 2359-2366, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34458934
10.
Analysis of Real-World Data to Investigate the Impact of Race and Ethnicity on Response to Programmed Cell Death-1 and Programmed Cell Death-Ligand 1 Inhibitors in Advanced Non-Small Cell Lung Cancers.
Oncologist
; 26(7): e1226-e1239, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33829580
11.
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II.
J Urol
; 205(1): 22-29, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32960678
12.
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I.
J Urol
; 205(1): 14-21, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32960679
13.
Clinical development of novel therapeutics for castration-resistant prostate cancer: historic challenges and recent successes.
CA Cancer J Clin
; 62(5): 299-308, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22535487
14.
Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2018.
J Urol
; 200(6): 1264-1272, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30086276
15.
The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer.
Cancer
; 123(18): 3532-3539, 2017 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28608931
16.
Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study.
Blood
; 136(1): 144-147, 2020 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32462179
17.
Sixty years of CA: a cancer journal for clinicians.
CA Cancer J Clin
; 60(6): 345-50, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21075954
18.
Clinical observations regarding the use of androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer.
Clin Adv Hematol Oncol
; 20 Suppl 9(5): 13-16, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579580
19.
Factors that guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer: Q&A.
Clin Adv Hematol Oncol
; 20 Suppl 9(5): 16-17, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579581
20.
A 2-Gene Panel Derived From Prostate Cancer-Enhanced Transcripts in Whole Blood Is Prognostic for Survival and Predicts Treatment Benefit in Metastatic Castration-Resistant Prostate Cancer.
Prostate
; 76(13): 1160-8, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27198487